Evidence map›Paper›PMID 37409260›Full record

ArticleFrontiers in oncology2023

Expression of

Eva Turyova, Peter Mikolajcik, Marian Grendar, Eva Kudelova, Veronika Holubekova, Michal Kalman, Juraj Marcinek, Matej Hrnciar, Michal Kovac, Juraj Miklusica and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Expression ofFrontiers in oncology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Eva TuryovaDepartment of Molecular Biology and Genomics, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin, Slovakia.
Peter MikolajcikClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University Bratislava, Martin, Slovakia.
Marian GrendarBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin, Slovakia.
Eva KudelovaClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University Bratislava, Martin, Slovakia.
Veronika HolubekovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin, Slovakia.
Michal KalmanDepartment of Pathological Anatomy, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University Bratislava, Martin, Slovakia.
Juraj MarcinekDepartment of Pathological Anatomy, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University Bratislava, Martin, Slovakia.
Matej HrnciarDepartment of Informatics, Information Systems and Software Engineering, Faculty of Informatics and Information Technologies, Slovak University of Technology, Bratislava, Slovakia.
Michal KovacDepartment of Informatics, Information Systems and Software Engineering, Faculty of Informatics and Information Technologies, Slovak University of Technology, Bratislava, Slovakia.
Juraj MiklusicaClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University Bratislava, Martin, Slovakia.
Ludovit LacaClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University Bratislava, Martin, Slovakia.
Zora LasabovaDepartment of Molecular Biology and Genomics, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin, Slovakia.
Comenius University Bratislava · SKSlovak University of Technology in Bratislava · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Colorectal cancer (CRC) is one of the most common types of cancer worldwide. The carcinogenesis of CRC is indeed complex, and there are many different mechanisms and pathways that contribute to the development of malignancy and the progression from primary to metastatic tumors. The OCT4A, encoded by the Methods: Surgical specimens from a total of 78 patients were collected and isolated from primary tumors ( Results: Our results suggest significantly downregulated expression of the Discussion: Unlike previous reports, we found out that the expression of

Indexed as

carcinogenesiscolorectal cancergene expressionisoformsoct4

Identifiers

PMID37409260
PMCPMC10319064
OpenAlexW4381334443

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.